Through network pharmacology, molecular docking, and molecular dynamics simulations, key bioactive compounds were identified and their interactions with MAO-B were determined, providing novel insights into the multi-target mechanisms of lingonberry in AD. This evidence concerns the gene MAOB and Alzheimer disease.